6.42 0.28 (4.56%)

74.06% Fall from 52W High

87,311 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

Karyopharm Therapeutics Inc - KPTI - stock price prediction, stock price target, analyst ratings from 7 analysts

Karyopharm Therapeutics Inc has a share price target of US$ 49, revenue growth forecast of 3.0%, and profit growth estimate of -82.6% for FY25, based on top 7 analyst calls.